SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-20-001154
Filing Date
2020-03-03
Accepted
2020-03-03 06:04:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-3 a2240851zf-3.htm F-3 199169
2 EX-5.1 a2240851zex-5_1.htm EX-5.1 8310
3 EX-8.2 a2240851zex-8_2.htm EX-8.2 5671
4 EX-23.3 a2240851zex-23_3.htm EX-23.3 3240
5 G129793.JPG g129793.jpg GRAPHIC 10015
6 G141788.JPG g141788.jpg GRAPHIC 20737
7 G401370.JPG g401370.jpg GRAPHIC 18500
8 G765412.JPG g765412.jpg GRAPHIC 5322
  Complete submission text file 0001047469-20-001154.txt   292389
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: F-3 | Act: 33 | File No.: 333-236851 | Film No.: 20679861
SIC: 2833 Medicinal Chemicals & Botanical Products